Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FNMVF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $65,633
Award facts
- Contract value 100% obligated
- $65,633.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $65,633.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda (pembrolizumab) 100 mg/4 mL vials. The delivery order, issued on July 23, 2025, with an ultimate completion date of August 13, 2025, carries no set-aside designation. This award represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026 under the SPE2DB program.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure multiple contracts with the Defense Logistics Agency for pharmaceutical distribution to Department of Defense healthcare facilities nationwide. The company's portfolio encompasses branded and generic prescription drugs, biologics, and medical consumables, with this delivery order specifically addressing the oncology treatment needs of military health facilities. The firm fixed-price structure and geographic designation of Park Ridge, Illinois as the place of performance reflect standard procurement practices for pharmaceutical distribution to federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FNMVF?
SPE2DB25FNMVF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 23, 2025.
How much is contract SPE2DB25FNMVF worth?
The government has obligated $65,633 on SPE2DB25FNMVF.
Is contract SPE2DB25FNMVF an order under another contract?
Yes. SPE2DB25FNMVF is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB25FNMVF competed?
The extent of competition for SPE2DB25FNMVF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award